Hypertensive pregnancy complications in poor and normal responders after in vitro fertilization

Fertility and Sterility

Volumn 93, Issue 2, 2010, Pages 652-657

  van Disseldorp, Jeroen ^a   Eijkemans, Rene ^a,b   Fauser, Bart ^a   Broekmans, Frank ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

In vitro fertilization; preeclampsia; pregnancy induced hypertension; response to gonadotropins

Indexed keywords

RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE INFERTILITY; MATERNAL HYPERTENSION; PREGNANCY; PRIORITY JOURNAL;

ADULT; BIRTH WEIGHT; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERTENSION; INFANT, NEWBORN; OVARIAN FOLLICLE; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, MULTIPLE; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 74449092069     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.01.092     Document Type: Article

References (49)

1. Maman E., Lunenfeld E., Levy A., Vardi H., and Potashnik G. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 70 (1998) 240-245
2. Shevell T., Malone F.D., Vidaver J., Porter T.F., Luthy D.A., Comstock C.H., et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 106 (2005) 1039-1045
3. Tallo C.P., Vohr B., Oh W., Rubin L.P., Seifer D.B., and Haning Jr. R.V. Maternal and neonatal morbidity associated with in vitro fertilization. J Pediatr 127 (1995) 794-800
4. Chu M.C., Rath K.M., Huie J., and Taylor H.S. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 18 (2003) 1570-1573
5. Kalantaridou S.N., Naka K.K., Papanikolaou E., Kazakos N., Kravariti M., Calis K.A., et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 89 (2004) 3907-3913
6. Bancsi L.F., Broekmans F.J., Mol B.W., Habbema J.D., and te Velde E.R. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79 (2003) 1091-1100
7. Broekmans F.J., Kwee J., Hendriks D.J., Mol B.W., and Lambalk C.B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12 (2006) 685-718
8. El-Toukhy T., Khalaf Y., Hart R., Taylor A., and Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve-an eight year study. Hum Reprod 17 (2002) 1519-1524
9. Battaglia C., Genazzani A.D., Regnani G., Primavera M.R., Petraglia F., and Volpe A. Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 74 (2000) 809-812
10. Woldringh G.H., Frunt M.H., Kremer J.A., and Spaanderman M.E. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Hum Reprod 21 (2006) 2948-2954
11. Kupesic S., Kurjak A., Bjelos D., and Vujisic S. Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age. Fertil Steril 79 (2003) 190-197
12. van der Schouw Y.T., van der Graaf Y., Steyerberg E.W., Eijkemans J.C., and Banga J.D. Age at menopause as a risk factor for cardiovascular mortality. Lancet 347 (1996) 714-718
13. Kok H.S., van Asselt K.M., van der Schouw Y.T., van der Tweel I., Peeters P.H., Wilson P.W., et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 47 (2006) 1976-1983
14. McIlveen M., Skull J.D., and Ledger W.L. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod 22 (2007) 778-785
15. Heard A.R., Dekker G.A., Chan A., Jacobs D.J., Vreeburg S.A., and Priest K.R. Hypertension during pregnancy in South Australia, part 1: pregnancy outcomes. Aust N Z J Obstet Gynaecol 44 (2004) 404-409
16. de Boer E.J., den Tonkelaar I., te Velde E.R., Burger C.W., and van Leeuwen F.E. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18 (2003) 1544-1552
17. Kailasam C., Keay S.D., Wilson P., Ford W.C., and Jenkins J.M. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 19 (2004) 1544-1547
18. Bancsi L.F., Broekmans F.J., Eijkemans M.J., de Jong F.H., Habbema J.D., and te Velde E.R. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77 (2002) 328-336
19. Ebrahim A., Rienhardt G., Morris S., Kruger T.F., Lombard C.J., and Van der Merwe J.P. Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response. J Assist Reprod Genet 10 (1993) 130-136
20. Fanchin R., de Ziegler D., Olivennes F., Taieb J., Dzik A., and Frydman R. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod 9 (1994) 1607-1611
21. Hendriks D.J., Broekmans F.J., Bancsi L.F., de Jong F.H., Looman C.W., and te Velde E.R. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum Reprod 20 (2005) 163-169
22. Creus M., Penarrubia J., Fabregues F., Vidal E., Carmona F., Casamitjana R., et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15 (2000) 2341-2346
23. Fabregues F., Balasch J., Creus M., Carmona F., Puerto B., Quinto L., et al. Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome. J Assist Reprod Genet 17 (2000) 13-19
24. Ranieri D.M., Quinn F., Makhlouf A., Khadum I., Ghutmi W., McGarrigle H., et al. Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 70 (1998) 227-233
25. Nargund G., Fauser B.C., Macklon N.S., Ombelet W., Nygren K., and Frydman R. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod 22 (2007) 2801-2804
26. The Netherlands Perinatal Registry. 2008. Available from: URL: http://www.perinatreg.nl.
27. Out H.J., Braat D.D., Lintsen B.M., Gurgan T., Bukulmez O., Gokmen O., et al. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation. Hum Reprod 15 (2000) 29-35
28. *) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril 79 (2003) 308-315
29. van Kooij R.J., Looman C.W., Habbema J.D., Dorland M., and te Velde E.R. Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril 66 (1996) 769-775
30. Brown M.A., Lindheimer M.D., de Swiet M., Van Assche A., and Moutquin J.M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20 (2001) IX-XIV
31. Koudstaal J., Braat D.D., Bruinse H.W., Naaktgeboren N., Vermeiden J.P., and Visser G.H. Obstetric outcome of singleton pregnancies after IVF: a matched control study in four Dutch university hospitals. Hum Reprod 15 (2000) 1819-1825
32. Verlaenen H., Cammu H., Derde M.P., and Amy J.J. Singleton pregnancy after in vitro fertilization: expectations and outcome. Obstet Gynecol 86 (1995) 906-910
33. Keegan D.A., Krey L.C., Chang H.C., and Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil Steril 87 (2007) 776-781
34. Pados G., Camus M., Van Steirteghem A., Bonduelle M., and Devroey P. The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 9 (1994) 538-542
35. Haller K., Salumets A., and Uibo R. Anti-FSH antibodies associate with poor outcome of ovarian stimulation in IVF. Reprod Biomed Online 16 (2008) 350-355
36. Loutradis D., Patsoula E., Minas V., Koussidis G.A., Antsaklis A., Michalas S., et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet 23 (2006) 177-184
37. Fauser B.C., Diedrich K., and Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 14 (2008) 1-14
38. Lass A., Gerrard A., Abusheikha N., Akagbosu F., and Brinsden P. IVF performance of women who have fluctuating early follicular FSH levels. J Assist Reprod Genet 17 (2000) 566-573
39. Lintsen A.M., Pasker-de Jong P.C., de Boer E.J., Burger C.W., Jansen C.A., Braat D.D., et al. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod 20 (2005) 1867-1875
40. Brosens I.A., De Sutter P., Hamerlynck T., Imeraj L., Yao Z., Cloke B., et al. Endometriosis is associated with a decreased risk of pre-eclampsia. Hum Reprod 22 (2007) 1725-1729
41. Griesinger G., Kolibianakis E.M., Diedrich K., and Ludwig M. Ovarian stimulation for IVF has no quantitative association with birthweight: a registry study. Hum Reprod 23 (2008) 2549-2554
42. Romundstad L.B., Romundstad P.R., Sunde A., von During V., Skjaerven R., Gunnell D., et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet 372 (2008) 737-743
43. Jenkins J.M., Davies D.W., Devonport H., Anthony F.W., Gadd S.C., Watson R.H., et al. Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 6 (1991) 918-921
44. Levi A.J., Raynault M.F., Bergh P.A., Drews M.R., Miller B.T., and Scott Jr. R.T. Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 76 (2001) 666-669
45. Veleva Z., Jarvela I.Y., Nuojua-Huttunen S., Martikainen H., and Tapanainen J.S. An initial low response predicts poor outcome in in vitro fertilization/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles. Fertil Steril 83 (2005) 1384-1390
46. Nasseri A., Mukherjee T., Grifo J.A., Noyes N., Krey L., and Copperman A.B. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril 71 (1999) 715-718
47. Buckett W.M., Chian R.C., Dean N.L., Sylvestre C., Holzer H.E., and Tan S.L. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril 90 (2008) 546-550
48. Galey-Fontaine J., Cedrin-Durnerin I., Chaibi R., Massin N., and Hugues J.N. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online 10 (2005) 94-99
49. Ulug U., Ben-Shlomo I., Turan E., Erden H.F., Akman M.A., and Bahceci M. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 6 (2003) 439-443